Home/Research/Post

Strategic Planning: FDA Could Further Strengthen Robust IT Modernization Plan

What GAO Found

The Food and Drug Administration (FDA) has developed a suite of strategic planning documentation to guide modernization of its information technology (IT) systems and support the agency’s IT strategic mission. FDA’s strategic plan suite identifies IT strategic goals and captures key upcoming agencywide modernization efforts. FDA’s strategic plans fully address six of eight strategic planning leading practices. For example, the plan aligns to agency and department-wide missions, identifies performance measures for meeting agency IT goals, and defines roles and responsibilities for meeting the goals.

Comparison of Food and Drug Adminstration (FDA) Strategic Plan Contents Against Leading Strategic Planning Practices

However, FDA has not fully documented ways to monitor mitigation of key challenges to achieve its IT strategic goals or identified links between its major IT investments and its strategic goals, consistent with leading practices. By including these details, FDA will be able to anticipate and overcome key challenges and effectively implement its major IT investments in line with strategic goals.

For the five large major IT investments selected by GAO for review, FDA fully addressed two and partially addressed one of three leading practices for performance measurement. Specifically, FDA created performance metrics for each investment that aligned with IT strategic goals and used these metrics to track investment performance. However, FDA did not demonstrate use of these metrics in managing and improving investment performance for one of the five investments. By doing so, FDA will be able to ensure that the investment is progressing as intended.

Why GAO Did This Study

FDA relies extensively on IT to achieve its mission for protecting the public’s health. GAO previously reported shortfalls in FDA’s ability to develop an IT strategic plan that was comprehensive and aligned with agency goals. The Consolidated Appropriations Act, 2023, called for FDA to develop an updated IT strategic plan.

The Act also includes provisions for GAO to assess the development of FDA’s IT strategic plan and the efficiency and effectiveness of its IT investments. This report examines the extent to which FDA has 1) developed a strategic plan to modernize its IT systems consistent with relevant leading practices; and 2) followed leading performance measurement practices in implementing its strategic plan for selected major IT investments.

GAO compared FDA’s IT strategic planning documents against leading practices for strategic planning. GAO also compared performance metrics for the five largest FDA major IT investments against leading practices for performance measurement. GAO supplemented this information by interviewing knowledgeable FDA officials.

Source: GAO Reports & Testimonies · 2026-11-18